CoChat

Randomized trial of the effect of drug presentation on asthma outcomes: The American Lung Association Asthma Clinical Research Centers

Open access
Wise, Robert A., Bartlett, Susan J., Brown, Ellen D., Castro, Mario, Cohen, Rubin, Holbrook, Janet T., Irvin, Charles G., Rand, Cynthia S., Sockrider, Marianna M., Sugar, Elizabeth A. · 2009 · Journal of Allergy and Clinical Immunology
Cited by 108

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background Information that enhances expectations about drug effectiveness improves the response to placebos for pain. Although asthma often improves with placebo, it is not known whether the response to placebo or active treatment can be augmented by increasing expectation of benefit. Objective The study objective was to determine if response to placebo or a leukotriene antagonist (montelukast) can be augmented by messages that increase expectation of benefit. Methods A randomized 20-center controlled trial enrolled 601 asthmatics with poor symptom control were assigned to one of five study groups. Participants were randomly assigned to either four treatment groups in a factorial design: placebo with enhanced messages, placebo with neutral messages, montelukast with enhanced messages, or montelukast with neutral messages; or to usual care. Assignment to study drug was double-masked; assignment to message content was single-masked; usual care was not masked. The enhanced message aimed to increase expectation of benefit from the drug. The primary outcome was mean change in daily peak-flow over 4 weeks. Secondary outcomes included lung function and asthma symptom control. Results Peak flow and other lung function measures were not improved in participants assigned to the enhanced message groups versus neutral messages groups for either montelukast or placebo; no differences were noted between neutral placebo and usual care groups. Placebo-treated participants had improved asthma control with the enhanced message, but not montelukast-treated participants; neutral placebo did have improved asthma control compared to usual care after adjusting for baseline difference. Headaches were more common in participants provided messages that mentioned headache as a montelukast side effect. Conclusions Optimistic drug presentation augments the placebo effect for patient-reported outcomes (asthma control), but not lung function. However, the effect of montelukast was not enhanced by optimistic messages regarding treatment effectiveness.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2009.05.041

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Wise, R. A., Bartlett, S. J., Brown, E. D., Castro, M., Cohen, R., Holbrook, J. T., Irvin, C. G., Rand, C. S., Sockrider, M. M., & Sugar, E. A.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2009-09
Volume
124
Issue
3
Pages
436-444.e8
ISSN
0091-6749 (ISSN-L)
OpenAlex
W1966615063
Cited by
108
References
5
FWCI
4.87
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.